Takeda Pharmaceutical news

Latest news

• 
  Biopharma's Leapfrog Moment: The Launch of the Digital CMC Consortium (opens in a new tab)

  PR Newswire · Oct 6, 2026

• Takeda (TSE:4502) Stock Looks Below Fair Value Even After A 120% Run (opens in a new tab)

  Oct 1, 2026

• 
  Corus International Receives $6.4 Million Grant From Takeda to Reduce Climate-Related Health Risks in Nepal (opens in a new tab)

  Oct 1, 2026

• Will Zasocitinib’s Phase 3 Outperformance Reshape Takeda Pharmaceutical's (TSE:4502) Immunology-Driven Pipeline Narrative (opens in a new tab)

  Oct 1, 2026

• Takeda Pharmaceutical (TSE:4502) Could Be 13% Undervalued On Strong Phase 3 Psoriasis Data (opens in a new tab)

  Sep 30, 2026

• Asian Equities Traded in the US as American Depositary Receipts Rise Modestly in Wednesday Trading (opens in a new tab)

  Sep 30, 2026

• Takeda Reports New Psoriasis Treatment Outperformed Competitor in Phase 3 Trial (opens in a new tab)

  Sep 30, 2026

• Zasocitinib Delivered Superior Efficacy Versus Deucravacitinib in New Phase 3 Head-to-Head Results, Reinforcing Potential to Deliver Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill (opens in a new tab)

  Sep 30, 2026

• KROS Begins Dosing in Phase II Study With Rinvatercept in DMD (opens in a new tab)

  Sep 29, 2026

• Ginkgo Datapoints and Apheris Welcome AbbVie, argenx, Lundbeck, and Takeda as Founding Members of the Antibody Developability Consortium (opens in a new tab)

  Sep 29, 2026

• Innovent Announces Expansion of Global Phase 3 MarsLight-11 Study of IBI363/TAK-928 (Alpha-biased IL-2/PD-1 Bispecific Fusion Protein) in Immunotherapy-Resistant NSCLC to Include Patients with Non-Squamous NSCLC (opens in a new tab)

  Sep 28, 2026

• Basecamp raises $140M before the clinic; J&J and Compass’ potential rivalry (opens in a new tab)

  Sep 25, 2026

• Takeda Highlights Late-Stage Oncology Pipeline Progress and Solid Tumor Portfolio Research, Led by Late-Breaking Phase 3 Arcotatug Tavatecan (TAK-921) Data, at ESMO 2026 (opens in a new tab)

  Sep 22, 2026

• Can Sotyktu's Long-Term PsA Data Boost Bristol Myers' Prospects? (opens in a new tab)

  Sep 18, 2026

• Takeda Employees Select Four New Global Corporate Social Responsibility Collaborations to Advance Climate-Resilient Health Systems (opens in a new tab)

  Sep 18, 2026

• Takeda Pharmaceutical (TAK) Gets Priority Review. Can Zasocitinib Win in Psoriasis? (opens in a new tab)

  Sep 17, 2026

• Do Novavax’s (NVAX) New Partnerships Offset Policy Risks From The Protecting Approved Care Act? (opens in a new tab)

  Sep 16, 2026

• Myelodysplastic Syndrome Market Set for Strong Growth During the Forecast Period (2026-2036) as Targeted Therapies and Novel Treatment Approaches Reshape the Landscape | DelveInsight (opens in a new tab)

  Sep 15, 2026

• Hummingbird Bioscience Appoints Dr. James Garner as President (opens in a new tab)

  Sep 15, 2026

• Asian Equities Traded in the US as American Depositary Receipts Fall Sharply in Monday Trading (opens in a new tab)

  Sep 14, 2026

• 
  Takeda CSO Chris Arendt on Transforming Drug Discovery & the R&D Pipeline (opens in a new tab)

  NYSE · Aug 10, 2026

• 
  Takeda and Indonesia partner on plasma-derived therapies (opens in a new tab)

  Pharmaceutical Technology · Jul 13, 2026

• 
  Takeda and the Indonesian Government Announce Landmark Collaboration to Strengthen Healthcare Resilience and Expand Access to Lifesaving Plasma-Derived Medicinal Products (opens in a new tab)

  Business Wire · Jul 12, 2026

• 
  Takeda Makes Fresh AI Drug Discovery Bet With Insilico Medicine (opens in a new tab)

  Benzinga · Jul 5, 2026

• 
  Takeda’s New AI Drug Discovery Deal With Insilico Might Change The Case For Investing In Takeda Pharmaceutical (TSE:4502) (opens in a new tab)

  Simply Wall St. · Jul 3, 2026

• 
  Insilico Medicine, Takeda partner on AI-driven drug discovery (opens in a new tab)

  Pharmaceutical Technology · Jul 2, 2026

• 
  Insilico Medicine Announces Collaboration with Takeda to Advance Strategic AI Drug Discovery (opens in a new tab)

  PR Newswire · Jul 2, 2026

• 
  Mass.’ largest biotech employer swings to near $1B loss after Boston jury delivers major blow (opens in a new tab)

  MassLive · Jun 20, 2026

• 
  Boltz Announces Collaboration with Takeda to Deploy Frontier Biomolecular AI Models Across Takeda's Research Organization (opens in a new tab)

  PR Newswire · Jun 18, 2026

• 
  Takeda (TSE:4502) Unveils Phase 3 Wins In Narcolepsy And Psoriasis (opens in a new tab)

  Simply Wall St. · Jun 16, 2026